Avanos Medical Q1 2024 Adj EPS $0.19 Misses $0.21 Estimate, Sales $166.100M Beat $162.900M Estimate
Avanos Medical Q1 2024 Adj EPS $0.19 Misses $0.21 Estimate, Sales $166.100M Beat $162.900M Estimate
Avanos Medical 2024年第一季度調整後每股收益0.19美元未達到0.21美元的預期，1.661億美元的銷售額超過1.629億美元的預期
Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.21 by 9.52 percent. This is a 29.63 percent decrease over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $166.100 million which beat the analyst consensus estimate of $162.900 million by 1.96 percent. This is a 4.27 percent increase over sales of $159.300 million the same period last year.
Avanos Medical（紐約證券交易所代碼：AVNS）公佈的季度收益爲每股0.19美元，比分析師普遍預期的0.21美元低9.52％。與去年同期的每股收益0.27美元相比，下降了29.63％。該公司公佈的季度銷售額爲1.661億美元，比分析師普遍預期的1.629億美元高出1.96％。這比去年同期的1.593億美元銷售額增長了4.27％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。